MediFind
Condition

Bullous Pemphigoid

Latest Research

Latest Advance
Study
  • Condition: Psychiatric Comorbidity in Individuals with Bullous Pemphigoid (BP)
  • Journal: BMC psychiatry
  • Treatment Used: Prescribed Medications
  • Number of Patients: 6470450
  • Published —
This study investigated the association between bullous pemphigoid (skin disorder; BP) and all bullous disorders (ABD) with a broad array of psychiatric disorders, exploring the influence of prescribed medications.
Latest Advance
Study
  • Condition: Benign Mucous Membrane Pemphigoid
  • Journal: The Journal of dermatological treatment
  • Treatment Used: Rituximab
  • Number of Patients: 24
  • Published —
This study tested the safety and efficacy of using rituximab to treat patients with benign mucous membrane pemphigoid.
Latest Advance
Study
  • Condition: Type 2 Diabetes Mellitus (T2DM)
  • Journal: Drug safety
  • Treatment Used: Alogliptin
  • Number of Patients: 0
  • Published —
This article preformed a benefit-risk assessment to place alogliptin within the current armamentarium of type 2 diabetes mellitus (T2DM) and aid physicians when choosing optimal diabetes treatment for their patients.
Latest Advance
Study
  • Condition: Bullous Pemphigoid (BP)
  • Journal: International journal of dermatology
  • Treatment Used: Dipeptidyl Peptidase-4 Inhibitors (DPP4i)
  • Number of Patients: 89
  • Published —
This study described the prevalence, socio-demographic, clinical, and histopathological characteristics, and outcome after drug withdrawal in with dipeptidyl peptidase-4 inhibitors (DPP4i)-associated bullous pemphigoid (large blisters; BP).
Latest Advance
Study
  • Condition: Immune-Mediated Disorders
  • Journal: Frontiers in immunology
  • Treatment Used: Rituximab
  • Number of Patients: 0
  • Published —
This study investigated the safety and efficacy of using rituximab to treat various immune-mediated disorders.
Latest Advance
Study
  • Condition: Ocular Surface Reconstruction
  • Journal: Cornea
  • Treatment Used: Autologous Cultivated Oral Mucosal Epithelial Transplantation (COMET)
  • Number of Patients: 24
  • Published —
This study evaluated the outcomes of autologous cultivated oral mucosal epithelial transplantation (COMET) in ocular surface reconstructive procedures.
Latest Advance
Study
  • Condition: Microbial Keratitis and Ocular Surface Disease (OSD)
  • Journal: Current eye research
  • Treatment Used: Antibiotics or Monotherapy Fluoroquinolones
  • Number of Patients: 171
  • Published —
This study reported he microbiological and clinical profiles, and outcomes of patients with microbial keratitis (inflammation of cornea) who had ocular surface disease (OSD) over a 5-year period.
Latest Advance
Study
  • Condition: Metastatic or Locally Advanced Inoperable Melanoma
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Nivolumab Combined With Stereotactic Body Radiation Therapy
  • Number of Patients: 20
  • Published —
In this study, researchers evaluated the safety and effectiveness of nivolumab combined with radiation therapy for the treatment of metastatic melanoma.
Latest Advance
Study
  • Condition: Bullous Phemphigoid
  • Journal: Journal of the American Academy of Dermatology
  • Treatment Used: Rituximab
  • Number of Patients: 20
  • Published —
This study tested the safety and efficacy of using rituximab to treat patients with bullous phemphigoid to treat patients with rituximab.
Latest Advance
Study
  • Condition: Refractory Autoimmune Bullous Diseases
  • Journal: The Journal of dermatology
  • Treatment Used: Rituximab Therapy
  • Number of Patients: 10
  • Published —
This study evaluated rituximab, a chimeric monoclonal immunoglobulin G antibody directed against CD20, for the treatment of refractory (recurrent) autoimmune bullous (blister) diseases both pemphigus (skin) and pemphigoid (mucous membrane).
Latest Advance
Study
  • Condition: Bullous Pemphigoid (BP)
  • Journal: International journal of dermatology
  • Treatment Used: Tetracycline, nicotinamide, and lesionally administered clobetasol versus prednisone.
  • Number of Patients: 106
  • Published —
This three year retrospective study was aimed at exploring clinical outcomes in patients with Bullous Pemphigoid (BP) when combining tetracycline, nicotinamide, and lesionally administered clobetasol (TNC) versus standardized treatment with prednisone (P).
Latest Advance
Study
  • Condition: Bullous Pemphigoid (BP) in Patients with Diabetes Mellitus
  • Journal: Journal of diabetes investigation
  • Treatment Used: Dipeptidyl Peptidase-4 Inhibitors
  • Number of Patients: 168
  • Published —
This study evaluated the relationship between bullous pemphigoid (BP) and dipeptidyl peptidase-4 inhibitors (DPP4Is) in patients with diabetes mellitus.